Explore 3 Stock Ideas & Industry Insights Download Free Report

News

This NYSE Consumer-Data Stock Just Hit A New 52-Week High After A Blowout Earnings Beat

NIQ Global Intelligence plc (NYSE:NIQ), the consumer-intelligence and market-research company formerly known as NielsenIQ, rose roughly 5.72% on August 20, 2026, extending a rally that began with its second-quarter 2026 earnings report on August 10, 2026. On the earnings date, shares jumped as much …

Nitish Kishor | 20 August 2026

This NYSE Power Producer Stock Is Rebounding Off 52-Week Lows On Renewed Data-Center Demand Optimism

NRG Energy, Inc. (NYSE:NRG), the Texas-based independent power producer, gained about 4.34% to $120.58 as investors bought back into a stock trading near its 52-week low. The rally builds on optimism around NRG's data-center power pipeline, including a Bring Your Own Power strategy with …

Nitish Kishor | 20 August 2026

Why Is Symbotic Inc. (NASDAQ:SYM) Stock Bouncing Near A 52-Week Low Today?

Symbotic Inc. (NASDAQ:SYM), theWarehouserobotics and automation company majority-owned through a long-termPartnershipwith Walmart, rose about 3.86% to $42.02 as shares bounced off levels near their 52-week low. The move came alongside a broader market advance that snapped a multi-day losing streak on August 19, 2026, …

Nitish Kishor | 20 August 2026

This NYSE Commercial Real Estate Stock Just Hit A New 52-Week High After A Blowout Earnings Beat

Jones Lang LaSalle Incorporated (NYSE:JLL) climbed about 5.17% on August 20, 2026, pushing the stock to within roughly 0.9% of its 52-week high. The move extends a rally that began July 30, 2026, when the commercial real estate services firm reported second-quarter adjustedEarnings Per …

Nitish Kishor | 20 August 2026

This NYSE Engineering Stock Is Rebounding Off 52-Week Lows After A $337 Million Project Charge Crushed Shares

AECOM (NYSE:ACM), the global engineering and infrastructure consulting firm, gained about 5.38% to $65.04, clawing back some ground after cratering to a 52-week low near $60.35 in the days following its August 11 fiscal third-quarter report. The bounce comes as analysts have largely stuck …

Nitish Kishor | 20 August 2026

Why Is QXO, Inc. (NYSE:QXO) Stock Bouncing Near A 52-Week Low Today?

QXO, Inc. (NYSE:QXO), the building products distribution consolidator led by CEO Brad Jacobs, rose about 4.52% to $14.11 as shares bounced off levels close to their 52-week low. The move follows Benchmark's reiteration of a Buy rating and $50 price target, which pointed to …

Nitish Kishor | 20 August 2026

This Nasdaq Genomics Stock Just Hit A New 52-Week High After Landing An Anthropic AI Protein Deal On Top Of Raised Guidance

Twist Bioscience Corporation (NASDAQ:TWST) surged after Anthropic announced on August 19, 2026 that it had selected the company as an independent evaluator to validate proteins designed by Anthropic's AI models, a role that leans on Twist's synthetic DNA and complex geneManufacturingcapabilities. The announcement reinforced …

Nitish Kishor | 20 August 2026

This Nasdaq Genomics Tools Stock Just Hit A New 52-Week High Extending Its Post-Earnings Rally

10x Genomics, Inc. (NASDAQ:TXG) has continued climbing toward a fresh 52-week high after reporting second-quarter 2026 results in early August that toppedWall Streetexpectations. The company posted revenue of $151.0 million versus a consensus estimate near $146.7 million and an adjusted per-share loss of $0.14, …

Nitish Kishor | 20 August 2026

This NYSE Animal-Health Stock Is Rebounding Off 52-Week Lows After A Guidance-Cut Overreaction

Zoetis Inc. (NYSE:ZTS) shares rose about 3.7% to $76.68 on Thursday, August 20, 2026, continuing a bounce that began after the stock touched a fresh 52-week low of $71.41 just three trading days earlier. The rally coincided with a broader market rebound: the U.S. …

Nitish Kishor | 20 August 2026

This Nasdaq Genomics Stock Just Hit A New 52-Week High Riding Strong Q2 Results And A Sector-Wide Biotech Rally

Illumina, Inc. (NASDAQ:ILMN) climbed toward a fresh 52-week high on August 19-20, 2026, a period that saw a broad rally across biotech and genomics stocks after Merck and Moderna announced positive Phase 3 melanoma vaccine trial results. Sector benchmarks including the S&P Biotech ETF …

Nitish Kishor | 20 August 2026
Support

Hi! How can we help you today?

Loading…